Article

Top Hepatitis C News of 2016

Author(s):

Lauren Santye, Assistant Editor

Top HCV articles of the year on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/top-hepatitis-c-news-of-2016" target="_blank">View the story "Top Hepatitis C News of 2016" on Storify</a>]

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
Tired scared retiree man holding chest with anginal symptoms, pallor and diaphoresis at home. Suffering male with cardiac origin pain, prexcordial pressure, arrhythmia risk, urgent medical attention - Image credit: DimaBerlin | stock.adobe.com
Image credit: Sebastian Kaulitzki | stock.adobe.com
Menoapuse spelled with wooden blocks -- Image credit: loran4a | stock.adobe.com
Related Content
FDA - U.S Food & Drug Administration
June 18th 2025

Midyear Roundup: FDA’s Novel Oncology Drug Approvals in 2025

Luke Halpern, Assistant Editor
Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education
February 28th 2025

Pharmacy Focus: Pharmacists' Role in Medical Cannabis Counseling and Patient Education

Luke Halpern, Assistant Editor Jill Simonian, PharmD Codi Peterson, PharmD, MS
Pharmacist administering IV in patient -- Image credit: Elnur | stock.adobe.com
June 16th 2025

Impact of a Community-Based Specialty Pharmacist in Identifying Drug Therapy Problems for New Adult Oncology Patients

Emma Hilgendorf, PharmD Danielle Chapman, PharmD Sarah Schmidt, PharmD Kajua Lor, PharmD, BCACP Kristin Busse, PharmD, BCPS
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Editor
The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence
June 13th 2025

The Evolving Role of the Pharmacist in HEOR: Bridging Clinical and Economic Evidence

Muhammad Cheema, PharmD, MPBA
Chronic kidney disease (CKD) -- Image credit: Kiattisak | stock.adobe.com
June 12th 2025

Finerenone and Empagliflozin Outperform Either Treatment Alone in Patients With CKD

Gillian McGovern, Associate Editor